![For Health Professionals](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/advisories_health_prof_2ndpage.jpg)
2006
December
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Important Safety Information on Attachment Handles for Portable Patient Lifts
- Notice to Hospitals
Date: 2006-12-08
|
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Important Safety Information on Xylocaine (lidocaine HCI) Jelly 2% Single Use Plastic Syringe (10 mL)
- Notice to Hospitals
- AstraZeneca Canada Inc.
Date: 2006-12-06
|
November
October
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Association of Avastin (bevacizumab) with hypertensive encephalopathy and reversible posterior leukoencephalopathy syndrome (RPLS)
- For Health Professionals
- For the Public
- Hoffmann - La Roche Limited
Date: 2006-10-27
|
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Association of CellCept (mycophenolate mofetil) and sirolimus containing immunosuppressant regimen with higher rate of acute rejection in cardiac transplant patients switched from calcineurin inhibitors
- For Health Professionals
- For the Public
- Hoffmann-La Roche Limited
Date: 2006-10-25
|
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Association of Syringe Infusion Pumps with a Risk of Delay in Detection of Downstream Occlusion
- Notice to Hospitals
Date: 2006-10-25
|
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Updated Safety Information on Ketek (telithromycin) and hepatic events, aggravation of myasthenia gravis and syncope
- For Health Professionals
- For the Public
- sanofi-aventis Canada Inc.
Date: 2006-10-03
|
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Important Safety Information on Gleevec (imatinib mesylate)
- For Health Professionals
- For the Public
- Novartis Pharmaceuticals Canada Inc.
Date: 2006-10-02
|
September
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Important Safety Information on the Alaris SE Pump (formerly Signature Edition Infusion Pump)
- Notice to Hospitals
- Cardinal Health
Date: 2006-09-19
|
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Important Safety Information on the recall of the Mallinckrodt Satin-Slip Intubating Stylet - 6 FR
- Notice to Hospitals
- Tyco Healthcare Canada
Date: 2006-09-14
|
August
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Association of a Rapamune (sirolimus) containing immunosuppressant regimen with a high rate of acute rejection in de novo renal transplant patients
- For Health Professionals
- For the Public
- Wyeth Pharmaceuticals
Date: 2006-08-24
|
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Association of Lamictal (lamotrigine) with an increased risk of non-syndromic oral clefts
- For Health Professionals
- For the Public
- GlaxoSmithKline Inc.
Date: 2006-08-08
|
July
June
May
April
March
February
January
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Association of WinRho SDF [Rho(D) Immune Globulin (Human)] with Intravascular Hemolysis in the treatment of Immune Thrombocytopenic Purpura
- Notice to Hospitals
- For the Public
- Cangene Corporation
Date: 2006-01-26
|
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Association of Macugen (pegaptanib sodium injection) with hypersensitivity reactions
- For Health Professionals
- For the Public
- Pfizer Canada Inc.
Date: 2006-01-23
|
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Important Safety Information on anti-TNFα Therapy: ENBREL (etanercept), HUMIRA (adalimumab), and REMICADE (infliximab)
- For Health Professionals
- For the Public
- Amgen Canada, Inc., Abbott Laboratories, Ltd., and Schering Canada, Inc.
Date: 2006-01-18
|
![arrow](/web/20061210203027im_/http://www.hc-sc.gc.ca/dhp-mps/medeff/images/arrow_bullet.gif) |
Association of Blood Lancing Devices with Transmission of Blood-Borne Diseases
- Notice to Hospitals
Date: 2006-01-13
|
|